Clinical diagnosis of GA of the macula secondary to AMD
GA lesions between 2.5 and 12.5 mm2 at screening
Sufficiently clear ocular media, adequate pupillary dilation and fixation to permit quality fundus imaging in the study eye as described in the protocol
Willing and able to comply with clinic visits and study-related procedures, including completion of the full series of meningococcal vaccinations and pneumococcal vaccination required per protocol
You may not be if
Has GA secondary to causes other than AMD
Has active ocular disease that compromises or confounds visual function
History of surgery for retinal detachment
Has ocular condition other than GA secondary to AMD
Use of intravitreal complement inhibitors in study eye
Hereditary or acquired complement deficiency
Active viral, bacterial or fungal infection
Liver injury as evidenced by abnormal liver function tests
Donating blood
History of choroidal neovascularization in the study eye
Clareo Health | Phase 2 Study of ADX-038 in Participants With Geographic Atrophy
